This study identified three potential biomarkers (RFC4, MCM2, TOP2A) of CESC which may be useful to clarify the underlying mechanisms of CESC and predict the prognosis of CESC patients. The gene discussed is RFC4; the disease is cervical squamous cell carcinoma.